Abstract:
The Brain Injury and Mechanism of Action of Hyperbaric Oxygen for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) (BIMA) study, sponsored by the Department of Defense and held under an investigational new drug application by the Office of the Army Surgeon General, is one of the largest and most complex clinical trials of hyperbaric oxygen (HBO₂) for post-concussive symptoms (PCS) in U.S. military service members.
Weaver, Chhoeu, Lindblad, Churchill, Deru, Wilson (2017). Executive summary: The Brain Injury and Mechanism of Action of Hyperbaric Oxygen for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) (BIMA) Study. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, ;43(5):485-489. https://www.ncbi.nlm.nih.gov/pubmed/28768068